PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21172227-8	2008	Treatment with either L. acidophilus (group III) or olsalazine (group IV) resulted in significant reduction in serum levels of CRP, TNF-alpha and IL-6, as well as disease activity index (DAI).	olsalazine	52-62	tumor necrosis factor	Rattus norvegicus	132-141	
21172227-9	2008	Treatment with combination of L. acidophilus and olsalazine (group V) offered more significant reduction in serum levels of CRP, TNF-alpha, IL-6 and disease activity index (DAI) when compared to either group II (untreated group), group III (treated with L. acidophilus) or group IV (treated with olsalazine).	olsalazine	49-59	tumor necrosis factor	Rattus norvegicus	129-138